FCB SAN FRANCISCO CEO RESIGNS

Move Follows Agency Loss of Calif. Lottery Account

By Published on .

Most Popular
SAN FRANCISCO (AdAge.com) -- Ian Beavis, president-CEO of the San Francisco office of Interpublic Group of Cos.'
Related Stories:
FCB LOST $125 MILLION ACCOUNT REVIEW BY A FAX
California Lottery Used Paperwork Technicality to Bounce Leading Contender
MCCANN-ERICKSON LATEST CALIF. LOTTERY WINNER
But $125 Million Ad Account Brawl May Not Be Over

Foote, Cone & Belding Worldwide, resigned today, according to the company.

The move comes after the office lost what appeared to be a sure thing for the five-year, $125 million California Lottery advertising account. FCB was disqualified when it faxed instead of delivered hard copies of a bid involving media costs.

No comment
Mr. Beavis declined to comment on the circumstances of his sudden departure.

FCB spokesman Bill Haney denied the lottery issue was involved in the decision. "Ian has decided to resign and pursue some other interests," he said.

Mr. Haney said Dominic Whittles, currently executive vice president and managing director, will take over as president of the office. "His top priority is on the creative product and developing a growth plan for the agency."

Mr. Beavis joined FCB, San Francisco, in September 2001. During his tenure, the office stabilized the Taco Bell account and increased its billings with Levi Stauss & Co. after winning design work for the Levi Strauss Signature jeans line to be sold in Wal-Mart Stores. He also was involved with the struggling San Francisco agency community, including serving as president of the International Advertising Association West.

Another CEO retires in New York
Meanwhile in New York, FCB HealthCare announced that president and general manager John Loden is retiring to make way for newly appointed co-CEOs Tom Domanico and Dana Maiman. The company said Mr. Loden was leaving to pursue other interests. He had been with the agency for 17 years.

Mr. Domanico was a founder of FCB HealthCare, previously known as Vicom, while Ms. Maiman has been part of its management team for the past four years. The unit's clients include Merck, Eli Lilly, Endo Pharmaceuticals and GlaxoSmithKline, among others.

In this article: